 "Is BMI enough to define obesity? Experts say it’s time for a new approach – Firstpost")
Relying solely on BMI to diagnose obesity may be outdated, say global experts. A new report calls for a more comprehensive approach, introducing ‘clinical’ and ‘pre-clinical’ obesity categories based on fat distribution and health impacts. This framework aims to improve diagnosis, reduce stigma, and personalise care for the over one billion people living with obesity worldwide … Read more
 "What is it? How does it work? – Firstpost")
The wait for India’s weight watchers is almost over. Weight loss drugs such as Ozempic, Zepbound, which have been huge hits in the American and European markets — Ozempic has been credited with boosting Denmark’s economy — will soon make its debut in the Indian markets. Last week, the apex drug regulator’s, Central Drug Standard … Read more
About 44% of U.S. employers with 500 or more employees cover drugs for weight loss in 2024, up from 41% in 2023, according to a survey from consulting firm Mercer released on Wednesday. Mercer also said 64% of U.S. employers with over 20,000 employees covered weight-loss drugs in 2024, compared with 56% last year. That … Read more
SHANGHAI, China — Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market, where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in … Read more
At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job. “I was in a really dark place,” said McKenzie, whose weight had climbed to 335 pounds on his 6-foot-1-inch frame, despite repeated efforts to diet and … Read more
LONDON: Novo Nordisk signed a research tie-up with US biotech firm Metaphore on Thursday to develop next-generation obesity drugs.Why it’s Important Danish drugmaker Novo is trying to expand beyond its blockbuster obesity drug Wegovy with at least eight other treatments in its R&D pipeline for the condition. The collaboration will use Metaphore’s tech platform to … Read more
SYDNEY: Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? This month, The Conversation’s experts explore their rise, impact and potential consequences.Many have declared drugs like Ozempic could “end obesity” by reducing the appetite and waistlines of millions of people around the … Read more
